Matthew E. Likens

Mr Likens is an accomplished leader in the medical device industry. Prior to coming to GT Medical Technologies, he served as the president and chief executive officer of Ulthera, Inc. There, he led the startup from pre-commercialization to more than $100M in revenue and a $600M acquisition by Merz Pharma GmbH.

Mr Likens’ professional career began with Johnson & Johnson. However, he spent the bulk of his career at Baxter Healthcare Corporation, where he progressed through a variety of domestic and international sales, marketing, and general management roles that ultimately culminated in the position of president of Baxter Biotech North America, and then the president of its US Renal Care division. After departing Merz in mid-2016, Mr Likens joined the board of Luma Therapeutics, a startup with a novel approach for the treatment of psoriasis, and CHF Solutions, a NASDAQ-listed company focused on supporting patients suffering from congestive heart failure due to fluid overload.